New drugs and diagnostic tests go through years of clinical trials before being approved. But while regulatory approval is an enormous hurdle, getting through that process doesn’t automatically ensure that patients have access to these medical innovations. Take a closer look.

New findings from the groundbreaking Trial Assigning Individualized Options for Treatment (Rx), or TAILORx trial, show no benefit from chemotherapy for 70 percent of women with the most common type of breast cancer. Take a closer look.

Gene mutations detected in blood may predict risk of one of the most common forms of adult leukemia a decade before patients are diagnosed with the disease, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators. Take a closer look.

Physicians in Albany Med’s Division of Urology are offering a new medication to treat prostate cancer that has been shown to reduce the risk of death from the disease as well as significantly lower the risk of cancer spreading to other parts of the body. Take a closer look.

Anthony Camnetar remembers the first time he was told that he had von Hippel-Lindau syndrome, a rare genetic disorder. He was 12 years old and his mother, who had just picked him up from school, broke the news through tears realizing the health challenges her son would face for the rest of his life. Take a closer look.

Keratin 17 (K17), a protein that promotes cancer, may prove to be a key target gene in the battle against pancreatic cancer. New research involving K17 as a therapeutic target against this lethal disease is being conducted by Kenneth Shroyer, MD, PhD, the Marvin Kuschner Professor and Chair of Pathology at Stony Brook Medicine, and Luisa Escobar-Hoyos, PhD, Assistant Professor and Co-Director of the Pathology Translational Research Lab. Take a closer look.

Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study led by Edward M. Messing, M.D., and an international clinical trials network funded by the National Cancer Institute. Take a closer look.

Research conducted at Albany Medical College could transform treatment and expand lifespans for people with glioblastoma, an aggressive brain tumor and one of the most deadly forms of cancer. Take a closer look.

Many cases of early-stage kidney cancer can be treated with a relatively new, nonsurgical procedure used to destroy tumors, a new study by a team led by Weill Cornell Medicine and NewYork-Presbyterian suggests. Take a closer look.

It’s been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying. Now, researchers at Albert Einstein College of Medicine, part of Montefiore, have discovered the secret to the gene’s success. Take a closer look.

A new high-throughput tool developed by scientists at Columbia University efficiently extracts information about the physical characteristics of a patient’s condition from electronic health records and automatically identifies associated candidate disease genes. Take a closer look.

Unable to carry signals based on sights and sounds to the genes that record memories, a broken shuttle protein may hinder learning in patients with intellectual disability, schizophrenia, and autism. This is the implication of a study led by researchers at NYU School of Medicine and published online June 22 in Nature Communications. Take a closer look.

Research scientists from the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and The Feinstein Institute for Medical Research in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases manifest and potentially can be treated.  Take a closer look.

Imagine a pathogen that infects completely healthy people and can cause blindness in one day and flesh-eating infections, brain abscesses and death in just a few days. Now imagine that this pathogen is also resistant to all antibiotics.  Take a closer look.

Among the most studied protein machines in history, mTORC1 has long been known to sense whether a cell has enough energy to build the proteins it needs to multiply as part of growth. Because faulty versions of mTORC1 contribute to the abnormal growth seen in cancer, drugs targeting the complex have been the subject of 1,300 clinical trials since 1970. Take a closer look.

While many people increase their exercise level to boost their metabolism, a recent study by Joanne Donoghue, Ph.D., assistant professor of osteopathic manipulation at NYIT College of Osteopathic Medicine (NYITCOM), found that female runners who run an average of 30 miles a week actually had a lower metabolism than women running an average of 10 to 12 miles a week. Take a closer look.

Survivors of opioid overdose are at great risk of dying in the year after overdose, but the deaths are not always caused by drug use, a new study reveals. In addition to succumbing to drug use, survivors were much more likely to die from respiratory diseases, viral hepatitis, and suicide.Take a closer look.

In a first-of-its-kind study, Mount Sinai researchers have used sensory mapping to discover that the posterior part of the larynx (closest to the swallowing tract) is the main area of the voice box to protect the airway from potentially dangerous swallowed or inhaled substances. This novel finding can potentially help doctors better understand and manage diseases affecting the larynx and lead to new, targeted treatments.  The results of this study have been published in the June online edition of The Laryngoscope. Take a closer look.

Marina Kaufman Holz, Ph.D., has been appointed dean of the Graduate School of Basic Medical Sciences at New York Medical College (NYMC) in Valhalla, N.Y. Her appointment comes at the end of an extensive, international search led by the Faculty Search Committee. Take a closer look.

Dr. Li Gan, a neuroscientist internationally acclaimed for her research into neurodegenerative diseases, has been appointed director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medicine. Take a closer look.

Zucker School of Medicine at Hofstra/Northwell student, Cassandra Gross, is a recipient of the 2018 AOA (Alpha Omega Alpha) Carolyn L. Kuckein Student Research Fellowship for an investigation that focused on distinguishing regions of interest in the aged human brainstem based on our understanding of animal gait circuits and pathways. Take a closer look.